Brain protection during mitral valve repair procedure
Part of Heart & circulation clinical trials.
This trial tests whether a special brain protection device can help reduce the risk of stroke during a common mitral valve repair procedure. It is for people with severe mitral regurgitation (leaky valve) who are already scheduled to have this repair.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have severe mitral regurgitation (a leaky heart valve that causes blood to flow backward).
- You have symptoms like shortness of breath or fatigue (NYHA class II or higher).
- You are already scheduled for a mitral valve repair procedure called TEER.
- You agree to the study and follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies an “epicardial” device placed during planned heart surgery to reduce mitral valve leaking (“mitral regurgitation”). If you have moderate-to-severe valve leak from ischemic heart disease and are already scheduled for heart surgery, this may help improve how well the valve works.
This trial tests a catheter-based procedure to repair a leaking mitral valve in people who are in severe heart shock and need medication support. The goal is to reduce the valve leak and see if it helps patients stabilize and recover.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
This study is testing if a special heart monitor can help patients who need mitral valve repair surgery. If you are scheduled for this surgery, the monitor will be placed during your procedure to track your heart function and recovery.
This study looks at how long a new mitral valve treatment/device can stay working in people with moderate-to-severe or severe mitral valve leak. It may help avoid or delay surgery for people considered higher risk for mitral valve repair.
This study looks at how safe and effective a specific catheter procedure is for people with moderate-to-severe mitral valve leakage. It may help those who are considered high risk for traditional open-heart surgery.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.